Rudolf M T, Li W H, Wolfson N, Traynor-Kaplan A E, Schultz C
Institut für Organische Chemie, Abt. Bioorganische Chemie, Universität Bremen UFT, Leobener Strasse, 28359 Bremen, Germany.
J Med Chem. 1998 Sep 10;41(19):3635-44. doi: 10.1021/jm970781n.
We have synthesized the first deoxy analogues of myo-inositol 3,4,5, 6-tetrakisphosphate (1) [Ins(3,4,5,6)P4], rac-2-deoxy-myo-inositol 3, 4,5,6-tetrakisphosphate (rac-2), 2-deoxy-myo-inositol 1,4,5, 6-tetrakisphosphate (ent-2), and rac-1-deoxy-myo-inositol 3,4,5, 6-tetrakisphosphate (rac-3). In order to evaluate the binding properties of the three derivatives to the yet unidentified intracellular binding sites for Ins(3,4,5,6)P4, the analogues were converted to membrane-permeant derivatives. Starting with common inositol precursors, various forms of Barton-McCombie deoxygenation and classical protection/deprotection procedures yielded the desired precursors rac-1-O-butyryl-2-deoxy-myo-inositol (rac-12), ent-3-O-butyryl-2-deoxy-myo-inositol (ent-12), and rac-2-O-butyryl-1-deoxy-myo-inositol (rac-19), respectively. Phosphorylation and subsequent deprotection yielded rac-2, ent-2, and rac-3. Alternatively, phosphorylation followed by alkylation with acetoxymethyl bromide gave the membrane-permeant derivatives 1-O-butyryl-2-deoxy-myo-inositol 3,4,5,6-tetrakisphosphate octakis(acetoxymethyl) ester (rac-5), 3-O-butyryl-2-deoxy-myo-inositol 1,4,5,6-tetrakisphosphate octakis(acetoxymethyl) ester (ent-5), and 2-O-butyryl-1-deoxy-myo-inositol 3,4,5,6-tetrakisphosphate octakis(acetoxymethyl) ester (rac-6), respectively. We examined the potency of the membrane-permeant deoxy derivatives in inhibition of calcium-mediated chloride secretion (CaMCS) in intact T84 cells. Compared to the 1,2-di-O-butyryl-myo-inositol 3,4,5, 6-tetrakisphosphate octakis(acetoxymethyl) ester (4), the membrane-permeant derivative of Ins(3,4,5,6)P4 (1), the 2-deoxy derivative (rac-5) exhibited a slightly weaker inhibitory effect, while the enantiomerically pure 2-deoxy-Ins(1,4,5,6)P4 (ent-5) and the 1-deoxy derivative (rac-6) were inactive. As expected, the effect was stereoselective. Thus, the 1-hydroxyl group is apparently essential for binding and the inhibitory effect of Ins(3,4,5,6)P4 on chloride secretion, whereas the 2-hydroxyl group plays a less important role.
我们合成了肌醇3,4,5,6 - 四磷酸(1)[Ins(3,4,5,6)P4]的首批脱氧类似物,即外消旋2 - 脱氧 - 肌醇3,4,5,6 - 四磷酸(rac - 2)、2 - 脱氧 - 肌醇1,4,5,6 - 四磷酸(对映体 - 2)和外消旋1 - 脱氧 - 肌醇3,4,5,6 - 四磷酸(rac - 3)。为了评估这三种衍生物与尚未明确的Ins(3,4,5,6)P4细胞内结合位点的结合特性,将这些类似物转化为可透过膜的衍生物。从常见的肌醇前体开始,通过各种形式的巴顿 - 麦康比脱氧反应以及经典的保护/脱保护程序,分别得到了所需的前体外消旋1 - O - 丁酰基 - 2 - 脱氧 - 肌醇(rac - 12)、对映体 - 3 - O - 丁酰基 - 2 - 脱氧 - 肌醇(对映体 - 12)和外消旋2 - O - 丁酰基 - 1 - 脱氧 - 肌醇(rac - 19)。磷酸化及随后的脱保护反应得到了rac - 2、对映体 - 2和rac - 3。或者,磷酸化后用溴代乙酰氧基甲基进行烷基化反应,分别得到了可透过膜的衍生物1 - O - 丁酰基 - 2 - 脱氧 - 肌醇3,4,5,6 - 四磷酸八(乙酰氧基甲基)酯(rac - 5)、3 - O - 丁酰基 - 2 - 脱氧 - 肌醇1,4,5,6 - 四磷酸八(乙酰氧基甲基)酯(对映体 - 5)和2 - O - 丁酰基 - 1 - 脱氧 - 肌醇3,4,5,6 - 四磷酸八(乙酰氧基甲基)酯(rac - 6)。我们检测了可透过膜的脱氧衍生物对完整T84细胞中钙介导的氯分泌(CaMCS)的抑制效力。与Ins(3,4,5,6)P4的可透过膜衍生物1,2 - 二 - O - 丁酰基 - 肌醇3,4,5,6 - 四磷酸八(乙酰氧基甲基)酯(4)相比,2 - 脱氧衍生物(rac - 5)表现出稍弱的抑制作用,而对映体纯的2 - 脱氧 - Ins(1,4,5,6)P4(对映体 - 5)和1 - 脱氧衍生物(rac - 6)无活性。正如预期的那样,这种作用具有立体选择性。因此,1 - 羟基显然对于结合以及Ins(3,4,5,6)P4对氯分泌的抑制作用至关重要,而2 - 羟基的作用则不太重要。